Duration: 30 minutes
Presented By: EBI & Constangy, Brooks, Smith & Prophete, LLP
Recorded from the live presentation on 12/14/17.
What You'll Learn:
- The 7 "to-do" items to prepare for the change
- How to update your drug testing policies & job descriptions
- How to communicate the new rule to your company & DOT service agents
- The notice that you need to provide to your employees & service agents now
In November 2017, the Department of Transportation (DOT) published a final rule in the Federal Register. Among other items, the rule added four semi-synthetic opioids -- hydrocodone, oxycodone, hydromorphone, and oxymorphone -- to the testing panel for all DOT regulated employees. It also modified the timing for Medical Review Officers (MROs) to communicate a significant safety risk or medically unqualified decision.
These changes go into effect January 1, 2018.
Watch this free, attorney-led webinar recording to learn what these changes mean for you as an employer, and the 7 things you need to do now to prepare your managers, drivers, and service agents for the the new rule.
Who Should Watch:
- Managers of DOT Programs
- HR Managers
- Safety & Risk Managers
- Corporate Attorneys
- Compliance Personnel
- Occupational Physicians
- Medical Examiners
About the Presenters:
Thomas M. Eden III
is Partner at Constangy, Brooks, Smith & Prophete, LLP. He serves as outside counsel to EBI and has developed employer policies in all 50 states and all DOT Agency modes. Tommy is a national speaker on the subject of marijuana in the workplace and many other workplace drug testing topics, including our webinars: Stand Firm! Solutions to Marijuana in the Workplace, New FMCSA Clearinghouse Regulations - 5 Ways They Impact Your DOT Fleet Now, and 30 Minute Marijuana Update and Q&A.
is a news anchor and journalist with nearly 20 years of experience in front of the camera. She's worked in several markets, large and small, and has performed nearly every task needed in a newsroom. As EBI's Screening News Editor, she keeps EBI's customers and blog subscribers up-to-date on the latest screening news and legislative alerts affecting companies of all sizes.